{{Rsnum
|rsid=1862513
|Gene=RETN
|Chromosome=19
|position=7668907
|Orientation=minus
|GMAF=0.3219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=RETN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 12.3 | 46.2 | 41.5
| HCB | 13.3 | 57.8 | 28.9
| JPT | 11.4 | 43.2 | 45.5
| YRI | 22.2 | 47.6 | 30.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 57.8 | 28.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19074981|OA=1
}} resistin levels

{{PMID|19178525}} (G;G) had the highest circulating resistin levels

{{PMID Auto
|PMID=19273568
|Title=Genetic variation in adipokine genes and risk of colorectal cancer
}}

{{PMID Auto
|PMID=19738363
|Title=A Pilot Study Suggests that the G/G Genotype of Resistin Single Nucleotide Polymorphism at -420 May Be an Independent Predictor of a Reduction in Fasting Plasma Glucose and Insulin Resistance by Pioglitazone in Type 2 Diabetes
}}

{{PMID Auto
|PMID=20300528
|Title=A at single nucleotide polymorphism-358 is required for g at -420 to confer the highest plasma resistin in the general Japanese population
|OA=1
}}
{{PMID Auto
|PMID=21190046
|Title=Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis
}}

{{PMID Auto
|PMID=15338456
|Title=The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
|OA=1
}}

{{PMID Auto
|PMID=15517149
|Title=Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects.
|OA=1
}}

{{PMID Auto
|PMID=16046815
|Title=Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=16642435
|Title=Cis- and trans-acting gene regulation is associated with osteoarthritis.
|OA=1
}}

{{PMID Auto
|PMID=16670163
|Title=Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians.
}}

{{PMID Auto
|PMID=18239575
|Title=Analysis of genetic variations in the resistin gene shows no associations with obesity in women.
}}

{{PMID Auto
|PMID=18498634
|Title=The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.
|OA=1
}}

{{PMID Auto
|PMID=18603647
|Title=Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.
|OA=1
}}

{{PMID Auto
|PMID=20131043
|Title=Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?
|OA=1
}}

{{PMID Auto
|PMID=21345288
|Title=Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients.
}}

{{PMID Auto
|PMID=23193185
|Title=Plasma Resistin Is Associated With Single Nucleotide Polymorphisms of a Possible Resistin Receptor, the Decorin Gene, in the General Japanese Population
|OA=1
}}

{{PMID Auto
|PMID=24008605
|Title=A polymorphism in the resistin gene promoter and the risk of multiple sclerosis
}}

{{PMID Auto
|PMID=23203410
|Title=Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study.
}}

{{PMID Auto
|PMID=23327840
|Title=Significant interaction between RETN -420 G/G genotype and lower BMI on decreased risk of type 2 diabetes mellitus (T2DM) in Japanese--the J-MICC Study.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}